WSGR logoWSGR logo
WSGR logo
  • Experience
  • People
  • Insights
  • About Us
  • Careers

  • Practice Areas
  • Industries

  • Corporate
  • Intellectual Property
  • Litigation
  • Patents and Innovations
  • Regulatory
  • Technology Transactions

  • Capital Markets
  • Corporate Governance
  • Corporate Life Sciences
  • Derivatives
  • Emerging Companies and Venture Capital
  • Employee Benefits and Compensation
  • Energy and Climate Solutions
  • Executive Advisory Program
  • Finance and Structured Finance
  • Fund Formation
  • Greater China
  • Mergers & Acquisitions
  • Private Equity
  • Public Company Representation
  • Real Estate
  • Restructuring
  • Shareholder Engagement and Activism
  • Tax
  • U.S. Expansion
  • Wealthtech

  • Special Purpose Acquisition Companies (SPACs)

  • Environmental, Social, and Governance

  • AI and Data Center Infrastructure
  • Energy Regulation and Competition
  • Project Development and M&A
  • Project Finance and Tax Credit Transactions
  • Sustainability and Decarbonization
  • Transportation Electrification

  • U.S. Expansion Library and Resources

  • Post-Grant Review
  • Trademark and Advertising

  • Antitrust Litigation
  • Arbitration
  • Board and Internal Investigations
  • Class Action Litigation
  • Commercial Litigation
  • Consumer Litigation
  • Corporate Governance Litigation
  • Employment Litigation
  • Executive Branch Updates
  • Government Investigations
  • Internet Strategy and Litigation
  • Patent Litigation
  • Securities Litigation
  • State Attorneys General
  • Supreme Court and Appellate Practice
  • Trade Secret Litigation
  • Trademark and Copyright Litigation
  • Trial
  • White Collar Crime

  • Advertising, Promotions, and Marketing
  • Antitrust and Competition
  • Committee on Foreign Investment in the U.S. (CFIUS)
  • Communications
  • Data, Privacy, and Cybersecurity
  • Export Control and Sanctions
  • FCPA and Anti-Corruption
  • FDA Regulatory, Healthcare, and Consumer Products
  • Federal Trade Commission
  • Fintech and Financial Services
  • Government Contracts
  • National Security and Trade
  • Payments
  • State Attorneys General
  • Strategic Risk and Crisis Management
  • Tariffs, Customs, and Import Compliance

  • Antitrust and Intellectual Property
  • Antitrust Civil Enforcement
  • Antitrust Compliance and Business Strategy
  • Antitrust Criminal Enforcement
  • Antitrust Litigation
  • Antitrust Merger Clearance
  • European Competition Law
  • Third-Party Merger and Non-Merger Antitrust Representation

  • Anti-Money Laundering
  • Foreign Ownership, Control, or Influence (FOCI)
  • Team Telecom

  • AI in Healthcare
  • Animal Health
  • Artificial Intelligence and Machine Learning
  • Aviation
  • Biotech
  • Blockchain and Cryptocurrency
  • Clean Energy
  • Climate and Clean Technologies
  • Communications and Networking
  • Consumer Products and Services
  • Data Storage and Cloud
  • Defense Tech
  • Diagnostics, Life Science Tools, and Deep Tech
  • Digital Health
  • Digital Media and Entertainment
  • Electronic Gaming
  • Fintech and Financial Services
  • FoodTech and AgTech
  • Global Generics
  • Internet
  • Life Sciences
  • Medical Devices
  • Mobile Devices
  • Mobility
  • NewSpace
  • Quantum Computing
  • Semiconductors
  • Software

  • Offices
  • Country Desks
  • Events
  • Community
  • Our Diversity
  • Sustainability
  • Our Values
  • Board of Directors
  • Management Team

  • Austin
  • Boston
  • Boulder
  • Brussels
  • Century City
  • Hong Kong
  • London
  • Los Angeles
  • New York
  • Palo Alto
  • Salt Lake City
  • San Diego
  • San Francisco
  • Seattle
  • Shanghai
  • Washington, D.C.
  • Wilmington, DE

  • Law Students
  • Judicial Clerks
  • Experienced Attorneys
  • Patent Agents
  • Business Professionals
  • Alternative Legal Careers
  • Contact Recruiting
Dawson Wong
Associate
Patents and Innovations
Washington, D.C.
djwong@wsgr.com

D202-973-8940

Download vCard
Open PDF

Dr. Dawson Wong is an associate in the Washington, D.C., office of Wilson Sonsini Goodrich & Rosati, where he is a member of the patents and innovations practice. His practice focuses on patent prosecution and counseling matters across multidisciplinary fields, including precision medicine, molecular diagnostics, bioinformatics, machine learning, medical devices, and medical imaging.

Prior to joining the firm, Dawson completed his doctoral degree in electrical engineering at Stanford University. His Ph.D. dissertation focused on the comprehensive image and transcriptomic analysis of single circulating tumor cells for liquid biopsy of lung cancer.

Experience

Dr. Dawson Wong is an associate in the Washington, D.C., office of Wilson Sonsini Goodrich & Rosati, where he is a member of the patents and innovations practice. His practice focuses on patent prosecution and counseling matters across multidisciplinary fields, including precision medicine, molecular diagnostics, bioinformatics, machine learning, medical devices, and medical imaging.

Prior to joining the firm, Dawson completed his doctoral degree in electrical engineering at Stanford University. His Ph.D. dissertation focused on the comprehensive image and transcriptomic analysis of single circulating tumor cells for liquid biopsy of lung cancer.

Education
  • J.D., Georgetown University Law Center
  • Ph.D., Electrical Engineering, Stanford University
  • M.S., Electrical Engineering, Stanford University
  • B.S., Computer Engineering, University of Illinois at Urbana-Champaign
  • B.S., Mathematics, University of Illinois at Urbana-Champaign
Admissions
  • Bar of the District of Columbia
  • U.S. Patent and Trademark Office
Credentials
Education
  • J.D., Georgetown University Law Center
  • Ph.D., Electrical Engineering, Stanford University
  • M.S., Electrical Engineering, Stanford University
  • B.S., Computer Engineering, University of Illinois at Urbana-Champaign
  • B.S., Mathematics, University of Illinois at Urbana-Champaign
Admissions
  • Bar of the District of Columbia
  • U.S. Patent and Trademark Office

Select Publications

  • Co-author, "Flow Homogenization Enables a Massively Parallel Fluidic Design for High-throughput and Multiplexed Cell Isolation," Advanced Materials Technologies, 2020
  • Co-author, "High-throughput full-length single-cell mRNA-seq of rare cells," PLoS ONE, 2017
  • Co-author, "Capture and Genetic Analysis of Circulating Tumor Cells Using a Magnetic Separation Device (Magnetic Sifter)," 1634 Circulating Tumor Cells, Methods in Molecular Biology 153-162, 2017
  • Co-author, "Multigene profiling of single circulating tumor cells," Molecular & Cellular Oncology, 2017
  • Co-author, "Molecular profiling of single circulating tumor cells from lung cancer patients," Proceedings of the National Academy of Sciences, 2016
  • Co-author, "Isolation and mutational analysis of circulating tumor cells from lung cancer patients with magnetic sifters and biochips," 14(1) Lab on a Chip 78-88, 2014
Insights

Select Publications

  • Co-author, "Flow Homogenization Enables a Massively Parallel Fluidic Design for High-throughput and Multiplexed Cell Isolation," Advanced Materials Technologies, 2020
  • Co-author, "High-throughput full-length single-cell mRNA-seq of rare cells," PLoS ONE, 2017
  • Co-author, "Capture and Genetic Analysis of Circulating Tumor Cells Using a Magnetic Separation Device (Magnetic Sifter)," 1634 Circulating Tumor Cells, Methods in Molecular Biology 153-162, 2017
  • Co-author, "Multigene profiling of single circulating tumor cells," Molecular & Cellular Oncology, 2017
  • Co-author, "Molecular profiling of single circulating tumor cells from lung cancer patients," Proceedings of the National Academy of Sciences, 2016
  • Co-author, "Isolation and mutational analysis of circulating tumor cells from lung cancer patients with magnetic sifters and biochips," 14(1) Lab on a Chip 78-88, 2014

Select Patents

  • Co-inventor, "Molecular analysis using a magnetic sifter and nanowell system," U.S. Patent No. 10,167,515, 2019
Patents

Select Patents

  • Co-inventor, "Molecular analysis using a magnetic sifter and nanowell system," U.S. Patent No. 10,167,515, 2019

Diagnostics and Medical Devices

  • Bioinformatic
  • Diagnostics

Engineering and Technology

  • AI
  • Biomechanics
  • Computer science
  • Electrical engineering
  • Machine learning

Genomics and Data Analysis

  • Bioinformatics algorithms
  • Computational biology
  • Next-generation sequencing
  • Sequencing

Miscellaneous

  • Cancer
Technical Fluency

Diagnostics and Medical Devices

  • Bioinformatic
  • Diagnostics

Engineering and Technology

  • AI
  • Biomechanics
  • Computer science
  • Electrical engineering
  • Machine learning

Genomics and Data Analysis

  • Bioinformatics algorithms
  • Computational biology
  • Next-generation sequencing
  • Sequencing

Miscellaneous

  • Cancer
Focus Areas
  • Artificial Intelligence and Machine Learning
  • Diagnostics, Life Science Tools, and Deep Tech
  • Intellectual Property
  • Life Sciences
  • Patents and Innovations
Recent Insights
Client Highlights
Wilson Sonsini Advises Freenome on IP Matters Related to $254 Million Funding
On February 15, 2024, Freenome, a biotechnology company developing blood tests for early cancer detection, announced it has raised $254 million in new funding from new and existing investors. Proceeds from the financing will help advance Freenome’s pipeline of single-cancer and tailored multi-cancer early detection tests built on its multiomics platform. Wilson Sonsini Goodrich & Rosati advised Freenome on IP matters related to the transaction.
Learn More
Alerts
Bipartisan Legislation Seeks to Clarify Which Inventions Are Patent Eligible
The U.S. patent system is based upon a quid pro quo balance that incentivizes innovation via a time-limited patent exclusivity, while encouraging the dissemination of new ideas for public benefit and use upon expiration of the patented innovation. However, for some innovative technologies, such as personalized medicine, diagnostics, and artificial intelligence (AI), case law developed within the past decade has made obtaining patent protection increasingly difficult. This has led to a lack of clarity and incentive for some innovators to develop technologies that may not be eligible for patent protection.1
Learn More
View All
  • people
  • insights
  • about us
  • careers
  • Binder
  • Alumni
  • Mailing List Signup
  • Client FTP Portal
  • Privacy Policy
  • Terms of Use
  • Accessibility
WSGR logo
Twitter
LinkedIn
Facebook
Instagram
Youtube
Copyright © 2026 Wilson Sonsini Goodrich & Rosati. All Rights Reserved.